Showing results (1-10 of 394) with videos related to
Sort By:
Pageof 40
Modern Rheumatology|August 19, 2007
Higher maximal serum concentration of methotrexate predicts the incidence of adverse reactions in Japanese rheumatoid arthritis patientsHirofumi Shoda, Shigeko Inokuma, Noriyuki Yajima, et al.Expert Opinion on Drug Safety|November 11, 2021
Search of official nationwide database in Japan for adverse events associated with disease-modifying antirheumatic drug therapies: focus on therapies in combination with methotrexateShigeko InokumaNihon Rinsho. Japanese Journal of Clinical Medicine|March 14, 2009
[How to find a collagen-vascular disease patient in an early stage and when to let her/him visit a rheumatologist]Shigeko InokumaExpert Opinion on Drug Safety|March 18, 2011
Leflunomide-induced interstitial pneumonitis might be a representative of disease-modifying antirheumatic drug-induced lung injuryShigeko InokumaChest|July 11, 2003
Visualization and functional consequence of pulmonary vascular impairment in patients with rheumatic diseasesHajime Kono, Shigeko InokumaAllergology International : Official Journal of the Japanese Society of Allergology|February 25, 2012
Eleven cases of angioedema with eosinophilia treated in a single hospital in JapanShinichiro Nakachi, Shigeko InokumaThe Journal of Rheumatology|March 17, 2010
Cytokine profiles of macrophage activation syndrome associated with rheumatic diseasesJunko Maruyama, Shigeko InokumaNihon Rinsho. Japanese Journal of Clinical Medicine|November 11, 2009
[Detection of allergen]Shoko Kobayashi, Shigeko InokumaInternal Medicine (Tokyo, Japan)|June 2, 2009
Intrapulmonary hemorrhage in collagen-vascular diseases includes a spectrum of underlying conditionsShoko Kobayashi, Shigeko InokumaInternal Medicine (Tokyo, Japan)|June 17, 2008
Inflammatory pseudotumors in multiple organs associated with elevated serum IgG4 level: recovery by only a small replacement dose of steroidHiroto Tsuboi, Shigeko Inokuma, Keigo Setoguchi, et al.Pageof 40